Cancer immunotherapy - an approach that removes the barriers that protect cancer cells from a patient's immune system - has revolutionized the treatment of many cancer types. About 40 percent of melanoma patients, for example, respond to immunotherapy, enabling the immune system's T cells to attack cancer cells and take control of the disease.